← Back to Search

Problem-Solving Therapy + BEACON App for Suicide Prevention

N/A

Waitlist Available

Led By Simon Hatcher, PhD

Research Sponsored by University of Ottawa

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Identifies as Male

18 years of age or older

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline; session 6; 3 months; 6 months post-enrollment

Awards & highlights

Study Summary

This trial is testing whether problem-solving therapy, supplemented by a smartphone app, is effective in treating men who present to the Emergency Department. 100 men will be enrolled and randomized to either receive face-to-face PST or face-to-face PST supplemented by the BEACON Suicide Prevention smartphone application.

Who is the study for?

This trial is for men over 18 who have self-harmed and visited an Emergency Department in Ontario within the last month. They must understand English, French, or Oji Cree, be willing to attend six therapy sessions using a smartphone app, return for follow-ups, and commit to a six-month study.Check my eligibility

What is being tested?

The study tests problem-solving therapy (PST) with or without the BEACON Suicide Prevention app for men after self-harm. Participants will receive face-to-face PST (possibly via videoconference), use the app if assigned, and share their experiences through interviews.See study design

What are the potential side effects?

While not explicitly listed in the provided information, potential side effects may include emotional discomfort or distress due to discussing sensitive topics during therapy sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I identify as male.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline; session 6; 3 months; 6 months post-enrollment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline; session 6; 3 months; 6 months post-enrollment

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline; session 6; 3 months; 6 months post-enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Measure of Suicidality - 24-Item Beck Scale for Suicidal Ideation (BSS)

Secondary outcome measures

Adherence to Masculine Gender Roles - 94-Item Conformity to Masculine Norms Scale (CMNI): Emotional Control Sub-Scale

Adherence to Masculine Gender Roles - 94-Item Conformity to Masculine Norms Scale (CMNI): Self-Reliance Sub-Scale

Change in Alcohol Misuse - 10-Item Alcohol Use Disorder Identification Test (AUDIT)

+17 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Blended-TherapyExperimental Treatment1 Intervention

Participants with receive six sessions of face-to-face PST supplemented by the BEACON platform.

Group II: PST AloneActive Control1 Intervention

Participants will receive six sessions of face-to-face PST.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of OttawaLead Sponsor

205 Previous Clinical Trials

265,991 Total Patients Enrolled

Ottawa Hospital Research InstituteOTHER

561 Previous Clinical Trials

2,785,591 Total Patients Enrolled

Simon Hatcher, PhDPrincipal InvestigatorUniversity of Ottawa

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What conditions are generally treated using Blended-Therapy?

"Blended-Therapy is a common treatment for nsaids. In addition, it can be employed to treat myriad conditions such as pain, acute distress and dysmenorrhea (menstrual pain)."

Answered by AI

How many volunteers are taking part in this experiment?

"Affirmative. Clinicaltrials.gov houses data indicating that recruitment for this medical study, which was initially published on March 31st 2020, is still in progress. The research requires 100 patients to be found from a single site."

Answered by AI

Is there an opportunity for volunteers to join this experiment?

"Affirmative. Evidence hosted on clinicaltrials.gov indicates that the research team is actively seeking participants, with recruitment beginning on March 31st 2020 and occurring across one medical centre with a target of 100 patients."

Answered by AI

Has there been any further research into Blended-Therapy protocols?

"Currently, 1 clinical trial is being conducted to research the effects of Blended-Therapy. No trials are presently in their third phase. Although most tests for this treatment occur in Ottawa, Ontario, there is one other medical site running related experiments."

Answered by AI

Recent research and studies

Social Psychiatry and Psychiatric EpidemiologyJournal

Self-harm in England: A Tale of Three Cities

Hawton, Keith, Helen Bergen, Deborah Casey, Sue Simkin, Ben Palmer, Jayne Cooper, Nav Kapur, et al.. 2007. “Self-harm in England: A Tale of Three Cities”. Social Psychiatry and Psychiatric Epidemiology. Springer Science and Business Media LLC. doi:10.1007/s00127-007-0199-7.

JAMA PsychiatryJournal

Risk of Suicide Following Deliberate Self-poisoning

Finkelstein, Yaron, Erin M. Macdonald, Simon Hollands, Marco L. A. Sivilotti, Janine R. Hutson, Muhammad M. Mamdani, Gideon Koren, and David N. Juurlink. 2015. “Risk of Suicide Following Deliberate Self-poisoning”. JAMA Psychiatry. American Medical Association (AMA). doi:10.1001/jamapsychiatry.2014.3188.

Emergency Medicine JournalJournal

Emergency Department Contact Prior to Suicide in Mental Health Patients

Da Cruz, D., A. Pearson, P. Saini, C. Miles, D. While, N. Swinson, A. Williams, J. Shaw, L. Appleby, and N. Kapur. 2010. “Emergency Department Contact Prior to Suicide in Mental Health Patients”. Emergency Medicine Journal. BMJ. doi:10.1136/emj.2009.081869.

British Journal of PsychiatryJournal